<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8BC88D56-0B5B-4A03-BB32-240AFB788165"><gtr:id>8BC88D56-0B5B-4A03-BB32-240AFB788165</gtr:id><gtr:name>Szeged University</gtr:name><gtr:address><gtr:line1>Szeged University</gtr:line1><gtr:line2>Dugonics ter 13</gtr:line2><gtr:line4>Szeged</gtr:line4><gtr:postCode>H-6720</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Hungary</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/628914BB-C55F-41DD-B3CE-2D20628675A4"><gtr:id>628914BB-C55F-41DD-B3CE-2D20628675A4</gtr:id><gtr:name>Hungarian Academy of Sciences (MTA)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4285C92D-5B37-452D-9E69-326C8C1FBA0C"><gtr:id>4285C92D-5B37-452D-9E69-326C8C1FBA0C</gtr:id><gtr:name>National Institute for Physiological Sciences</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0B638AA-F9B3-48E6-A841-17B44A6152C9"><gtr:id>C0B638AA-F9B3-48E6-A841-17B44A6152C9</gtr:id><gtr:name>University of Portsmouth</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8BC88D56-0B5B-4A03-BB32-240AFB788165"><gtr:id>8BC88D56-0B5B-4A03-BB32-240AFB788165</gtr:id><gtr:name>Szeged University</gtr:name><gtr:address><gtr:line1>Szeged University</gtr:line1><gtr:line2>Dugonics ter 13</gtr:line2><gtr:line4>Szeged</gtr:line4><gtr:postCode>H-6720</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Hungary</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/628914BB-C55F-41DD-B3CE-2D20628675A4"><gtr:id>628914BB-C55F-41DD-B3CE-2D20628675A4</gtr:id><gtr:name>Hungarian Academy of Sciences (MTA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4285C92D-5B37-452D-9E69-326C8C1FBA0C"><gtr:id>4285C92D-5B37-452D-9E69-326C8C1FBA0C</gtr:id><gtr:name>National Institute for Physiological Sciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0B638AA-F9B3-48E6-A841-17B44A6152C9"><gtr:id>C0B638AA-F9B3-48E6-A841-17B44A6152C9</gtr:id><gtr:name>University of Portsmouth</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4DB09770-AE0C-4CC3-9AB7-DE7636649565"><gtr:id>4DB09770-AE0C-4CC3-9AB7-DE7636649565</gtr:id><gtr:firstName>R</gtr:firstName><gtr:surname>Mcllhinney</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6583B699-A7E0-4288-9AE9-BF139A661D39"><gtr:id>6583B699-A7E0-4288-9AE9-BF139A661D39</gtr:id><gtr:firstName>P</gtr:firstName><gtr:surname>Somogyi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12020%2F4"><gtr:id>DBD824EE-0BAB-41FA-983D-DFD35B05A4A4</gtr:id><gtr:title>Functions and molecular characterization of novel GABAB receptor interacting proteins</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12020/4</gtr:grantReference><gtr:abstractText>In the human brain, nerve cells are activated by the amino acid, glutamic acid, whereas a related chemical, ? -amino butyric acid (GABA) is responsible for the inhibition of the activity of nerve cells. These effects are mediated by different receptor proteins that bind these chemical messengers specifically, and inform the cell about their presence in the extracellular space in the brain. The rapid responses to binding of these chemicals are caused by the opening of ion channels, whilst slower responses are the result of activating different glutamate and GABA receptors, which leads to the production of secondary messengers inside the cell. Over-stimulation, or failure to respond, of any of these receptors can lead to a variety of pathological conditions. Therefore, these receptors are important targets for therapeutic intervention in diseases such as epilepsy, anxiety, depression and neuronal death following strokes. Our research program is designed to increase our understanding of these receptors in terms of their structure, and their interactions with other proteins that can modulate their function and targeting on the surface of nerve cells. We are therefore characterising the structure of the AMPA and N-methyl-D-aspartate receptor (subtypes of the glutamate receptors) and the protein interactions of second messenger coupled receptors, focussing on the GABAB receptor</gtr:abstractText><gtr:technicalSummary>Glutamate receptors mediate most of the fast excitatory neurotransmission in the central nervous system, whilst ?-amino butyric acid (GABA) receptors mediate inhibitory neurotransmission. Whilst both of these receptors utilize ion channels for fast signalling, they also have second messenger-coupled receptors that modulate neurotransmission on longer time scales. The ion channels opened by glutamate include the N-methyl-D aspartate (NMDA) receptor, which has an important role in learning and memory. The second messenger coupled receptors for glutamate (mGluRs) and GABA (GABAB receptor are also important therapeutic targets for a range of pathological conditions, including epilepsy, neuro-excitotoxicity, anxiety and depression. Understanding the structure and function of these receptors is, therefore, extremely important, especially as it has become apparent that they function in large molecular complexes, which can modulate their responses. This project aims to characterize the novel proteins, identified in previous studies, that contribute to these complexes for the GABAB receptor. Previous work in the laboratory identified an important role for the N-terminal domain of the NMDA-receptor in receptor assembly. To pursue this further we have established a collaboration with Dr Radu Aricescu (Wellcome Trust Centre for Human Genetics, Oxford) who is MRC funded to examine the structures of the ionotropic glutamate receptor family. Preliminary results show that a soluble form of the domain obtained from the AMPA receptor subunit GluR2, can be crystallized, and does indeed oligomerize. This work continues and has been extended to look at interactions of other neuronal proteins. Recently we found evidence for the association of the GABAB receptor with members of the copine family of proteins, and with the chloride transporter KCC2. Collaborative studies with Dr. Colin Akerman (Dept. Pharmacology, Oxford) has revealed that activation of the GABAB receptor causes a rapid and sustained decrease in the activity of KCC2. Currently experiments are being carried out to determine the mechanism behind this phenomenon and how it is regulated. The copines are a relatively little studied family of proteins but two members of the family are brain specific and one, copine 6, shows evidence of neuronal activity related changes in amount. The proteins are thought to move proteins to the plasma mambrane in response to changes in intracellular calcium./ Our current work is aimed at testing this hypothesis and characterizing the function of these proteins in the brain. This will involve the use of siRNA knockdown of the proteins in cultured neurones, the production of antibodies to them and the use of mutated and domain swapped versions of the proteins to perturb their function.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-07-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>199000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Portsmouth</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy and Biomedical Sciences Portsmouth</gtr:department><gtr:description>Swinny J</gtr:description><gtr:id>49DF45DD-788A-4245-8564-E8FCAE88321B</gtr:id><gtr:impact>Kasugai, Y., Swinny, J.D., Roberts, J.D.B., Dalezios, Y., Fukazawa, Y., Sieghart, W., Shigemoto, R. &amp;amp; Somogyi, P. (2010) Quantitative localisation of synaptic and extrasynaptic GABAA receptor subunits on hippocampal pyramidal cells by freeze-fracture replica immunolabelling. Eur. J. Neurosci. 30:Online:doi:10.1111/j.1460- 9568.2010.07473.x</gtr:impact><gtr:outcomeId>WFycLE3pUjP-1</gtr:outcomeId><gtr:partnerContribution>Experimental work</gtr:partnerContribution><gtr:piContribution>Provided reagents, experimental design and know-how</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Lamsa K</gtr:description><gtr:id>869AAAF9-C68F-4596-B18B-85EDA541FB31</gtr:id><gtr:impact>Oren I (2009) J Neurosci 29, 939-950
Nissen (2010) J Neurosci 30, 1337-1247
Somogyi, J. (2012) Frontiers in Neural Circuits 6, 1-6</gtr:impact><gtr:outcomeId>hrGq9LRX4nX-1</gtr:outcomeId><gtr:partnerContribution>Introducing innovative neuronal recording and pharmacological analysis of synaptic interactions in brain slices. Discoveries.</gtr:partnerContribution><gtr:piContribution>Identification of recorded cells, design of experiments, antibodies and training of University staff.
Award of a 5 year Wellcome Research Fellowship to Dr Lamsa</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hungarian Academy of Sciences (MTA)</gtr:collaboratingOrganisation><gtr:country>Hungary, Republic of</gtr:country><gtr:department>Institute of Experimental Medicine</gtr:department><gtr:description>Freund, T. F.</gtr:description><gtr:id>8A12CF28-12CA-49F2-A7BB-C53E26B03190</gtr:id><gtr:impact>Ascoli (2008) Nature Re Neurosci 9, 557-568</gtr:impact><gtr:outcomeId>esL1sJaHSbr-1</gtr:outcomeId><gtr:partnerContribution>experimental data and analysis</gtr:partnerContribution><gtr:piContribution>Experimental data and design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Szeged</gtr:collaboratingOrganisation><gtr:country>Hungary, Republic of</gtr:country><gtr:department>Department of Pharmacology and Pharmacotherapy</gtr:department><gtr:description>G. Tamas</gtr:description><gtr:id>79B06BD7-B7F8-484D-AB59-D13451BEC64F</gtr:id><gtr:impact>Varga C, Tamas G, Barzo P, Olah S and Somogyi P. (2015) Molecular and electrophysiological characterization of GABAergic interneurons expressing the transcription factor COUP-TFII in the adult human temporal cortex. Cereb. Cortex. 25, 4430-4449.</gtr:impact><gtr:outcomeId>DKV34tuF4dV-1</gtr:outcomeId><gtr:partnerContribution>Experimental data and analysis</gtr:partnerContribution><gtr:piContribution>Experimental data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Physiological Sciences</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>Division of Cerebral Structure</gtr:department><gtr:description>Shigemoto R</gtr:description><gtr:id>44BE88FE-D5F2-4FB3-90BB-E51F3BC03FA3</gtr:id><gtr:impact>Kasugai, Y., Swinny, J.D., Roberts, J.D.B., Dalezios, Y., Fukazawa, Y., Sieghart, W., Shigemoto, R. &amp;amp; Somogyi, P. (2010) Quantitative localisation of synaptic and extrasynaptic GABAA receptor subunits on hippocampal pyramidal cells by freeze-fracture replica immunolabelling. Eur. J. Neurosci. 30:Online:doi:10.1111/j.1460- 9568.2010.07473.x</gtr:impact><gtr:outcomeId>f3CTTQrVS4B-1</gtr:outcomeId><gtr:partnerContribution>Provided facilities in Japan, training, reagents and know-how</gtr:partnerContribution><gtr:piContribution>Experimental design, experimental work, data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Vienna</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Center for Brain Research</gtr:department><gtr:description>Klausberger T</gtr:description><gtr:id>293896DE-C308-4DD6-97B9-3CFA248C5683</gtr:id><gtr:impact>Fuentealba, P., Klausberger, T., Karayannis, T., Suen, W.Y., Huck, J., Tomioka, R., Rockland, K., Capogna, M., Studer, M., Morales, M. &amp;amp; Somogyi, P. (2010) Expression of COUP-TFII nuclear receptor in restricted GABAergic neuronal populations in the adult rat hippocampus. J. Neurosci. 30:1595-1609.</gtr:impact><gtr:outcomeId>Td1zW4Rbckc-1</gtr:outcomeId><gtr:partnerContribution>Joint experiments and training of MRC personnel in advanced elecrophysiological methods. Design of research projects.</gtr:partnerContribution><gtr:piContribution>We have conducted joint experiments and analysis of data and helped with experimental design.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12020/4</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>